Predictive factors for long-term survival in patients with advanced ovarian cancer
- 1 July 1989
- journal article
- research article
- Published by Elsevier in Gynecologic Oncology
- Vol. 34 (1) , 88-93
- https://doi.org/10.1016/0090-8258(89)90114-5
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- A critical reassessment of second-look laparotomy in epithelial ovarian carcinomaCancer, 1986
- Chemotherapy of advanced ovarian adenocarcinoma: A randomized comparison of combination versus sequential therapy using chlorambucil and cisplatinGynecologic Oncology, 1986
- Prognosis of surgically determined complete responders in advanced ovarian cancerCancer, 1985
- Treatment of advanced and recurrent ovarian carcinoma with cyclophosphamide, doxorubicin, and cisplatinCancer, 1984
- Long-term survival after chemotherapy for advanced epithelial ovarian carcinomaAmerican Journal of Obstetrics and Gynecology, 1984
- Prognostic factors in malignant epithelial ovarian tumorsGynecologic Oncology, 1983
- Cis-platin based combination chemotherapy for advanced ovarian cancer. High overall response rate with curative potential only in women with small tumor burdensCancer, 1983
- Combination chemotherapy with adriamycin-cyclophosphamide for advanced ovarian carcinomaCancer, 1980
- Advanced ovarian cancer correlation of histologic grade with response to therapy and survivalCancer, 1980
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958